StockData
Kardigan, Inc. logo

Kardigan, Inc. (KARD) shareholders

KARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$13.19+0.34 (+2.65%)

Close on Nov 17, 2026Market cap $1.23BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
61.2%
57M of 94M shares
Institutional holders
69
69 new, 0 sold out
Net institutional buying
57M
In Q2 2026
Insider trades, 12 months
3 buys · 0 sales
Net bought $90.00M

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Kevin Anthony Kelly
Joint filing with Hrtg Gpe, LLC ("hrtg") (18.20%), Keith Bryon Johnson (18.20%) and 1 more
16,917,03418.20%13G (passive)Jun 22, 2026
Paul Berns
Joint filing with ARCH Venture Fund XIII, L.P. (16.20%), ARCH Venture Partners XIII, L.P. (16.20%) and 5 more
15,095,51816.20%13D (active)Jun 22, 2026
Gianakakos Anastasios10,470,29411.10%13G (passive)Jun 30, 2026
FMR LLC
Joint filing with Abigail P. Johnson (10.30%)
9,221,77410.30%13G (passive) amendmentJul 31, 2026
Joseph Edelman
Joint filing with Perceptive Advisors LLC (8.90%), Perceptive Capital Solutions Holdings LP (6.20%)
8,254,1448.90%13D (active)Jun 18, 2026
Perceptive Advisors LLC
Joint filing with Joseph Edelman (8.80%), Perceptive Capital Solutions Holdings LP (6.20%)
8,254,1448.80%13D (active) amendmentSep 29, 2026
Edelberg Jay4,878,1055.20%13G (passive)Jun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of KARDValueChange% of portfolio
Schf (Gpe), LLC16,917,03418.09%$403.47MNew16.26%
FMR LLC8,909,0669.53%$212.48MNew0.01%
Perceptive Advisors LLC8,200,6628.77%$195.59MNew2.94%
T. Rowe Price Investment Management, Inc.4,207,1304.50%$100.34MNew0.07%
Capital Research Global Investors3,598,9423.85%$85.83MNew0.01%
JPMorgan Chase & Co1,790,7341.92%$46.38MNew0.00%
Alliancebernstein L.P.1,534,8371.64%$36.61MNew0.01%
Liberty Mutual Group Asset Management Inc.1,196,4111.28%$28.53MNew2.49%
Jennison Associates LLC903,5750.97%$21.55MNew0.01%
Paradigm Biocapital Advisors LP900,0000.96%$21.47MNew0.40%
Jupiter Topco LLC749,7030.80%$17.72MNew0.01%
Price T Rowe Associates Inc /Md/658,7870.70%$15.71MNew0.00%
Massachusetts Financial Services Co /Ma/650,0000.70%$15.50MNew0.00%
Goldman Sachs Group Inc644,9690.69%$15.38MNew0.00%
Deep Track Capital, LP600,0000.64%$14.31MNew0.21%
Woodline Partners LP413,9800.44%$9.87MNew0.03%
Franklin Resources Inc400,0210.43%$9.54MNew0.00%
Suvretta Capital Management, LLC400,0000.43%$9.54MNew0.17%
Bank of New York Mellon Corp377,7580.40%$9.01MNew0.00%
Catalio Capital Management, LP312,5000.33%$7.45MNew1.40%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20266957M61.2%69 / 00 / 057M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

FundShares% of KARDValue% of fundAs of
SMALLCAP World Fund Inc3,503,8423.75%$83.57M0.09%Jun 30, 2026
Fidelity Contrafund1,090,6451.17%$26.01M0.01%Jun 30, 2026
JPMorgan Small Cap Growth Fund823,5980.88%$19.64M0.75%Jun 30, 2026
AB Small Cap Growth Portfolio741,8830.79%$17.69M0.56%Jun 30, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.737,2330.79%$17.58M0.19%Jun 30, 2026
T. Rowe Price Small-Cap Value Fund, Inc.633,3070.68%$15.10M0.14%Jun 30, 2026
Eventide Healthcare & Life Sciences Fund596,4110.64%$14.22M0.80%Jun 30, 2026
T. Rowe Price New Horizons Fund, Inc.445,2530.48%$10.62M0.07%Jun 30, 2026
T. Rowe Price Institutional Small-Cap Stock Fund398,5700.43%$9.51M0.19%Jun 30, 2026
Fidelity Blue Chip Growth Fund352,1000.38%$7.33M0.01%Jul 31, 2026
Eventide Healthcare & Life Sciences Fund300,0000.32%$7.16M0.40%Jun 30, 2026
JPMorgan Small Cap Blend Fund265,2420.28%$6.33M0.37%Jun 30, 2026
Fidelity Contrafund K6227,4930.24%$5.43M0.01%Jun 30, 2026
SmallCap Growth Fund I225,6470.24%$4.70M0.19%Jul 31, 2026
BNY Mellon Small/Mid Cap Growth Fund182,2970.19%$4.35M0.50%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Anastasios GianakakosPresident & CEO, Director9,806,63310.49%Jun 22, 2026
John B. MoriartyChief Legal Officer47,7840.05%Jun 22, 2026
Jay EdelbergChief Medical Officer4,595,3834.91%Jun 22, 2026
Andy PasternakChief Strategy Officer79,6400.09%Jun 22, 2026
Brianne JahnChief Financial Officer79,6400.09%Jun 22, 2026
Kristin Marie K. ReinkeDirector––Oct 1, 2026
Advisors Llc PerceptiveDirector––Jul 13, 2026
Capital Solutions Holdings LP PerceptiveDirector––Jul 13, 2026
Joseph EdelmanDirector20,7060.02%Jul 13, 2026
Life Sciences Master Fund Ltd PerceptiveDirector––Jul 13, 2026
Kristina BurowDirector, 10% owner––Jun 24, 2026
Paul L. BernsDirector, 10% owner15,062,74116.11%Jun 24, 2026
Steven GillisDirector, 10% owner––Jun 24, 2026
ARCH Venture Partners XIII, LLCDirector, 10% owner––Jun 24, 2026
ARCH Venture Fund XIII, L.P.Director, 10% owner––Jun 24, 2026
ARCH Venture Partners XIII, L.P.Director, 10% owner––Jun 24, 2026
Keith CrandellDirector, 10% owner––Jun 24, 2026
Robert NelsenDirector, 10% owner15,042,03516.09%Jun 24, 2026
David P. MeekerDirector20,7060.02%Jun 22, 2026
Kimberly J. PopovitsDirector20,7060.02%Jun 22, 2026
Douglas E. GiordanoDirector20,7060.02%Jun 22, 2026
Timothy P. WalbertDirector20,7060.02%Jun 22, 2026
Keith Bryon Johnson10% owner13,792,03414.75%Jun 24, 2026
Kevin Anthony Kelly10% owner––Jun 24, 2026
Schf Cif 2024, L.P.10% owner––Jun 24, 2026
Hrtg Pv, L.P.10% owner16,917,03418.09%Jun 24, 2026
Hrtg Gpe, Llc10% owner––Jun 24, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Robert Nelsen
Director, 10% owner
Jun 22, 2026Buy+1,250,000$16.00$20.00M15,042,035
Paul L. Berns
Director, 10% owner
Jun 22, 2026Buy+1,250,000$16.00$20.00M15,042,035
Hrtg Pv, L.P.
10% owner
Jun 22, 2026Buy+3,125,000$16.00$50.00M14,866,868
Joseph Edelman
Director
Jun 17, 2026Award+20,706––20,706
Douglas E. Giordano
Director
Jun 17, 2026Award+20,706––20,706
Andy Pasternak
Chief Strategy Officer
Jun 17, 2026Award+79,640––79,640
Keith Bryon Johnson
10% owner
Jun 17, 2026Conversion+2,348,373––11,741,868
Keith Bryon Johnson
10% owner
Jun 17, 2026Conversion+3,242,993––9,393,495
Keith Bryon Johnson
10% owner
Jun 17, 2026Conversion+6,150,502––6,150,502
Keith Bryon Johnson
10% owner
Jun 17, 2026Conversion+2,050,166––2,050,166
Brianne Jahn
Chief Financial Officer
Jun 17, 2026Award+79,640––79,640
Anastasios Gianakakos
President & CEO, Director
Jun 17, 2026Conversion+41,001––2,422,520
Anastasios Gianakakos
President & CEO, Director
Jun 17, 2026Conversion+28,702––5,665,090
Anastasios Gianakakos
President & CEO, Director
Jun 17, 2026Conversion+498,692––498,692
John B. Moriarty
Chief Legal Officer
Jun 17, 2026Award+47,784––47,784
Jay Edelberg
Chief Medical Officer
Jun 17, 2026Conversion+97,587––135,543
Jay Edelberg
Chief Medical Officer
Jun 17, 2026Award+47,784––183,327
Kimberly J. Popovits
Director
Jun 17, 2026Award+20,706––20,706
Paul L. Berns
Director, 10% owner
Jun 17, 2026Award+20,706––20,706
Paul L. Berns
Director, 10% owner
Jun 17, 2026Conversion+13,792,035––13,792,035
Robert Nelsen
10% owner
Jun 17, 2026Conversion+13,792,035––13,792,035
Timothy P. Walbert
Director
Jun 17, 2026Award+20,706––20,706
David P. Meeker
Director
Jun 17, 2026Award+20,706––20,706

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
15.14%
6M shares short
Days to cover
11.2
At 1M shares a day
Change since last report
+7.4%
From 5M shares
Short volume, 20 days
69.2%
Of volume reported to FINRA

Shares sold short, last 5 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Kardigan's stock actually held short. Settlement fails (shares not delivered on time) peaked at 89,530 shares on Sep 21, 2026 over the last 90 days.

See a number that looks wrong?